Rare diseases
Investigational molecules
Locations
Back to Denmark778 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Phase 2 Study Evaluating Safety and Efficacy of Belzutifan in Adults with Solid Tumors
DenmarkLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
DenmarkStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
DenmarkStudy of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers
DenmarkTezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis
DenmarkPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
DenmarkA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
DenmarkStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
DenmarkA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
DenmarkEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
DenmarkCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
DenmarkCevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.
These trials support more effective day-to-day management of patients with unstable heart conditions.
Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.
This work may help refine care for people with advanced liver disease.
Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.
These studies aim to strengthen precision treatment for selected colorectal cancer patients.
Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.
These trials are designed to support faster, more effective treatment decisions after stroke.
Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.
These trials reflect active interest in advancing antiviral research in Denmark.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
